English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
New iCMLf Prize to recognize work in the emerging regions
New iCMLf Prize to recognize work in the emerging regions: nominate now
March 2015 - The iCMLf is very pleased to announce a new prize recognizing outstanding contributions to overcome the challenge of treatingCML with limited resources. The Emerging Regions Support and Partnership (ERSAP) Prize will be awarded each year to an individual, or organisation that has made outstanding contributions to the treatment of CML in the emerging economic regions.
John Goldman Prize 2015
The 2015 iCMLf Goldman Prize is awarded to Professor Michele
Baccarani
February 2015 - The annual Goldman Prize awarded by the iCMLf in honour of Professor John Goldman complements the iCMLf’s Rowley Prize as a clinical equivalent recognising outstanding lifetime contributions to the management of patients with CML. The iCMLf awards the 2015 Goldman Prize to Professor Michele Baccarani in recognition of his over forty years of dedication to clinical excellence in the management of CML.
Janet Rowley Prize 2015
The 2015 iCMLf Rowley Prize is awarded to Professor Richard Van Etten
February 2015 - The iCMLf Rowley Prize is designed to recognise persons who have made major contributions to the understanding of the biology of CML. In 2015 the Rowley Prize is awarded to Professor Richard Van Etten. This iCMLf award recognises Dr Van Etten’s groundbreaking research focusing on the development of new therapeutic strategies such as the tyrosine kinase inhibitors.
Annual Report 2013/2014
iCMLf Annual Report - what has the iCMLf accomplished in the last 12 months?
September 2014 - We are delighted to present the iCMLf Annual Report 2013/2014. It features the Foundation’s activities from Sept 1st 2013 to August 31st 2014.
Key outcomes from the iCMLf in the last 12 months include:
- With 22 personalised preceptorships at 11 CML centres of excellence the iCMLf Clinical Preceptorship Program continues to have far reaching and long-term impact on the management of CML.
- The iCMLf Diagnosis and Testing program to build local, sustainable capacity for CML diagnostics has been widely extended by funding 9 Phase I projects and 4 Phase II projects this year.
- Visitors to the iCMLf website came from 80% of all countries around the world. With 130,000 page impressions per month and over 24,000 visitors per month the iCMLf website goes a long way to address a global audience.
- Cases in the interactive online Clinical Case Discussion Forum have had over 16,000 views this year.
Patient Education
Patient Education: two useful resources to share with your CML patients
October 2014 - ‘Patient education is an essential supplement to good professional healthcare.’* With the on going success of TKI therapies and greater numbers of CML patients remaining on treatment, many for life, people who have an interest in self-education will continue to grow. Patient specific educational resources are very valuable and we share two of these with you today. We hope these are useful, not only for our members who are patients and or patient advocates, but also for physicians around the world to share with their patients.
iCMLf Website is relaunched
New Structure and a Fresh Look: the iCMLf Website is relaunched
August 2014 - The iCMLf has relaunched its website. Programs, discussions and education on this interactive platform now have a new structure and a fresh new look to make the multi-layered content more accessible. We invite you to see and look for yourself on a tour around the new website.
